Back to top
more

Rockwell Medical (RMTI)

(Real Time Quote from BATS)

$3.40 USD

3.40
172,265

-0.09 (-2.58%)

Updated Oct 15, 2024 02:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (62 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Amwell Shares Rise After Expansion of Portfolio With Hello Heart

AMWL adds Hello Heart to its clinical programs, offering heart health solutions to members with high blood pressure or cholesterol via its Converge platform.

DaVita Stock Gains 47.3% Year to Date: What's Behind the Rally?

DVA's strong performance and growth strategies, including patient-centric care and international expansion, position it well for continued success despite potential risks.

Merit Medical Stock Gains 24.7% Year to Date: What's Behind the Rally?

MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.

Trinity Biotech Shares Surge on Positive Pre-Pivotal Clinical CGM Trial

TRIB announces positive results from its pre-pivotal clinical European trial for a next-gen continuous glucose monitor, setting the stage for further development in 2025.

Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run?

Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Urmimala Biswas headshot

Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?

RMTI continues to outperform its peers, banking on its focus on optimizing business to drive sustainable profitability and meaningful cash flow generation.

Rockwell Medical (RMTI) is a Great Momentum Stock: Should You Buy?

Does Rockwell Medical (RMTI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Rockwell Medical, Inc. (RMTI) Hit a 52 Week High, Can the Run Continue?

Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run?

Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Fast-paced Momentum Stock Rockwell Medical (RMTI) Is Still Trading at a Bargain

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Rockwell Medical (RMTI) Tops Q2 Earnings and Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 125% and 12.26%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Jushi Holdings Inc. (JUSHF) Reports Q2 Loss, Lags Revenue Estimates

Jushi Holdings Inc. (JUSHF) delivered earnings and revenue surprises of 83.33% and 3.81%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates

TG Therapeutics (TGTX) delivered earnings and revenue surprises of 200% and 11.12%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates

Evolus (EOLS) delivered earnings and revenue surprises of -75% and 2.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 60% and 7.06%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

InMode (INMD) Q1 Earnings and Revenues Beat Estimates

InMode (INMD) delivered earnings and revenue surprises of 12.50% and 0.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical (RMTI) Increases Despite Market Slip: Here's What You Need to Know

In the latest trading session, Rockwell Medical (RMTI) closed at $1.65, marking a +1.85% move from the previous day.

Rockwell Medical (RMTI) Q4 Earnings and Revenues Beat Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 125% and 0.01%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical (RMTI) Rises As Market Takes a Dip: Key Facts

Rockwell Medical (RMTI) concluded the recent trading session at $1.54, signifying a +1.32% move from its prior day's close.

Rockwell Medical (RMTI) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.48, denoting a +0.68% change from the preceding trading day.

Rockwell Medical (RMTI) Flat As Market Gains: What You Should Know

In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.37, denoting no change from the preceding trading day.

Why Rockwell Medical (RMTI) Dipped More Than Broader Market Today

In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.34, denoting a -0.74% change from the preceding trading day.

Rockwell Medical (RMTI) Flat As Market Gains: What You Should Know

Rockwell Medical (RMTI) closed at $1.29 in the latest trading session, marking no change from the prior day.

Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 41.67% and 0.43%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?